single48MG
Neuroxelin
48MG Protocol
Neuroxelin 48MG
Injection Freq.
Inject once daily
Cycle Sched.
8–12 weeks; re-assess every 8 weeks for extension
Reconstitution
3.0 mL BAC water
Improved neurological outcomes and functional recovery signals in related-peptide literature
Cognitive test improvements (e.g., MoCA / processing speed) reported in cited supplementation studies
Reduced neuronal death and microglial activation in animal studies
Low-toxicity profile reported for related peptides vs placebo in trials
1
Reconstitution Requirements
- 3.0 mL BAC water
| Step | Week Range | Dose | Units |
|---|---|---|---|
| 1 | Weeks 1–4 | 500 mcg | 3 |
| 2 | Weeks 5–8 | 750 mcg | 4.7 |
Inject once daily
8–12 weeks; re-assess every 8 weeks for extension
Neuroxelin is presented as a neuroprotective peptide concept aimed at intervening in multiple steps of the brain-injury cascade. The protocol describes potential attenuation of excitotoxic neuronal death by disrupting NMDA-receptor–linked signaling complexes (referencing mechanisms similar to PSD-95–interaction inhibitors). It also highlights neuroinflammation as a target: Neuroxelin-class peptides are described as downregulating microglial activation and reducing inflammatory cytokine signaling, which can help limit secondary injury after stroke or traumatic brain injury. A third theme is repair support—promoting synaptic recovery, neurogenesis, neuronal survival, and vascular repair processes over weeks of consistent administration. Rather than acting as a single receptor agonist, Neuroxelin is framed as a multi-mechanism neuropeptide strategy with a goal of improving functional outcomes and cognitive recovery metrics in research contexts, drawing on preclinical and related-peptide clinical literature for plausibility.
Mild injection-site reactions (redness/irritation)
- Use aseptic technique: wipe vial stopper with alcohol; use new sterile syringe/needle
- Add diluent slowly down the vial wall to minimize foaming
- Gently swirl/roll until fully dissolved (do not shake)
- Label vial with reconstitution date and concentration; protect from light
- Refrigerate after reconstitution (commonly 2–8 °C) unless protocol states otherwise
- Avoid repeated freeze–thaw cycles
- Bacteriostatic Water for Injection contains benzyl alcohol preservative (multi-dose); follow protocol for beyond-use (many peptide protocols use ~28 days after mixing)
- Avoid benzyl-alcohol-containing diluents in neonates/infants (safety warning for benzyl alcohol)